GLP-1 agonists: US sees 700% increase over four years in number of patients without diabetes starting treatment. Mahase E. BMJ 2024;386:q1645.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mahase E. GLP-1 agonists: US sees 700% increase over four years in number of patients without diabetes starting treatment. BMJ 2024;386:q1645.
PMID: 39043396